Management of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia With Open Prostatectomy: Results of a Contemporary Series
- 31 December 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 176 (6), 2557-2561
- https://doi.org/10.1016/j.juro.2006.07.143
Abstract
Purpose: Surgical therapy remains the definitive treatment in patients with benign prostatic hyperplasia sequelae. Many patients with a markedly enlarged prostate are often not amenable to minimally invasive therapies. In these patients open prostatectomy is a preferred treatment. Most studies of this procedure are quite dated. Therefore, we describe the clinical results and complications of open prostatectomy performed in a modern setting using serum prostate specific antigen, the American Urological Association symptom index and quality of life scores to determine outcomes. Materials and Methods: We performed a prospective study in 56 patients who underwent open prostatectomy at our institution. Patients were evaluated by history and physical examination, American Urological Association symptom index, quality of life forms, prostate specific antigen, transrectal ultrasound and post-void urine volume. Results: Patients were followed up to 11 years postoperatively (mean 39.2 months). Of the patients 80.3% presented in acute urinary retention while on medical therapy. Baseline American Urological Association symptom index decreased from a mean ± SD of 18.5 ± 1.9 to 4 ± 1.7 within 1 month. Similarly the quality of life score was 3.1 ± 0.5 preoperatively, which decreased to 0.6 ± 0.5 postoperatively. These improvements were maintained throughout followup. The most common complication was blood loss requiring transfusion in approximately 36% of cases. Three patients had urethral strictures and 3 had bladder neck contractures that required dilation. Baseline average prostate specific antigen was 13.34 ± 1.70 ng/dl, which stabilized at less than 1 ng/dl postoperatively. Conclusions: Open prostatectomy may be curative in a select population of men with a large prostatic burden. To our knowledge this is the first study to demonstrate durable improvements in American Urological Association symptom index, quality of life score and prostate specific antigen along with a rare need for any further treatment after open prostatectomy.Keywords
This publication has 16 references indexed in Scilit:
- The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992–2002)BJU International, 2005
- Prostate-Specific Antigen as an Estimator of Prostate Volume in the Management of Patients with Symptomatic Benign Prostatic HyperplasiaEuropean Urology, 2003
- Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventionsUrology, 2002
- TRANSURETHRAL RESECTION OF THE PROSTATE AMONG MEDICARE BENEFICIARIES: 1984 TO 1997Journal of Urology, 2000
- Management of symptomatic BPH in the US: who is treated and how?European Urology, 1999
- The Natural History of Patients With Benign Prostatic Hyperplasia as Diagnosed by North American UrologistsJournal of Urology, 1997
- The outcome of suprapubic prostatectomy: A contemporary series in the developing worldUrology, 1995
- New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United StatesArchives of Internal Medicine, 1995
- An Aid for Hemostasis in Open Prostatectomy: Capsular LicationJournal of Urology, 1982
- Low Suprapubic Prostatectomy: Comparison of Results with the Standard Operation in Two Comparable Groups of 142 PatientsJournal of Urology, 1963